AlzChem Group AG (ACT) — Strategic Asset Allocation Index
AlzChem Group AG (ACT) has a Strategic Asset Allocation Index of 112.5% as of September 2023. Strategic assets (PP&E of €181.57 Million plus long-term investments of €-) total €181.57 Million, measured against net assets of €161.44 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
AlzChem Group AG Strategic Asset Allocation Index (2017–2022)
This chart shows how AlzChem Group AG's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of September 2023, the index stands at 112.5%, representing strategic assets of €181.57 Million against net assets of €161.44 Million EUR. Explore AlzChem Group AG operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for AlzChem Group AG (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for AlzChem Group AG from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see AlzChem Group AG (ACT) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 122.3% | €178.44 Million | €178.44 Million | €- | €145.95 Million | ▼ -73.2 pp |
| 2021 | 195.5% | €175.10 Million | €175.10 Million | €- | €89.56 Million | ▼ -41.9 pp |
| 2020 | 237.4% | €163.01 Million | €163.01 Million | €- | €68.66 Million | ▼ -33.8 pp |
| 2019 | 271.3% | €166.43 Million | €166.43 Million | €- | €61.35 Million | ▲ +118.8 pp |
| 2018 | 152.5% | €104.30 Million | €104.30 Million | €- | €68.39 Million | ▼ -19.2 pp |
| 2017 | 171.7% | €99.39 Million | €99.39 Million | €- | €57.89 Million | — |